Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results

    Financial Results - Page 14

    Lupin reports 31 percent year on year fall in Q2 net profit

    Lupin reports 31 percent year on year fall in Q2 net profit

    savita thakur thakur31 Oct 2017 2:47 PM IST
    Mumbai: Pharma Major Lupin Limited reported its financial performance for the second quarter ending September 30th, 2017. These results were taken on...
    GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr

    GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr

    Ruby Khatun Khatun28 Oct 2017 9:46 AM IST
    New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals reported a 31.83 percent rise in standalone net profit to Rs 130.32 crore for the second quarter...
    Medtronic misses revenue estimates, shares dip

    Medtronic misses revenue estimates, shares dip

    Ruby Khatun Khatun24 Aug 2017 9:30 AM IST
    Medical device maker Medtronic Plc on Tuesday reported quarterly revenue fell short of analysts' estimates, hurt by lower sales in its...
    Aurobindo Pharma Q1 net profit down 11 percent at Rs 518 crore

    Aurobindo Pharma Q1 net profit down 11 percent at Rs 518 crore

    Ruby Khatun Khatun20 Aug 2017 10:15 AM IST
    New Delhi: Aurobindo Pharma Ltd reported an 11.38% decline in consolidated net profit at Rs 518.33 crore for the first quarter ended 30 June 2017.The...
    Granules India revenue increases by 10 percent to Rs 386 Crore

    Granules India revenue increases by 10 percent to Rs 386 Crore

    Ruby Khatun Khatun18 Aug 2017 9:45 AM IST
    HYDERABAD: Granules India Ltd., a growing pharmaceutical manufacturing company, announced financial results for its first quarter ended 30th June,...
    Cipla shares surge over 6 percent after Q1 earnings

    Cipla shares surge over 6 percent after Q1 earnings

    Ruby Khatun Khatun17 Aug 2017 11:59 AM IST
    New Delhi: Shares of drug major Cipla rose over 6 per cent after the company reported 23.63 per cent rise in consolidated net profit for the first...
    Apollo Hospitals Q1 net profit tumbles 51 percent to Rs 35.21 crore

    Apollo Hospitals Q1 net profit tumbles 51 percent to Rs 35.21 crore

    Ruby Khatun Khatun16 Aug 2017 12:03 PM IST
    New Delhi: Apollo Hospitals Enterprise on Monday reported 51.21 per cent dip in standalone net profit to Rs 35.21 crore for June 2017 quarter, mainly...
    Abbott India Q1 net profit down 35 percent at Rs 48 crore

    Abbott India Q1 net profit down 35 percent at Rs 48 crore

    Ruby Khatun Khatun10 Aug 2017 9:16 AM IST
    New Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended...
    Natco Pharma Q1 profit up 97 percent at Rs 93.7 crore

    Natco Pharma Q1 profit up 97 percent at Rs 93.7 crore

    Ruby Khatun Khatun8 Aug 2017 9:20 AM IST
    New Delhi: Drug firm Natco Pharma on Monday reported a 97.26 per cent rise in consolidated profit after tax to Rs 93.7 crore for the first quarter...
    Narayana Hrudayalaya Q1 net profit slips 36% to Rs 11 crore

    Narayana Hrudayalaya Q1 net profit slips 36% to Rs 11 crore

    Ruby Khatun Khatun5 Aug 2017 9:30 AM IST
    Mumbai: Narayana Hrudayalaya Ltd reported a 36 per cent decline in net profit at Rs 10.9 crore in the first quarter ended June 30 from Rs 17.2 crore...
    Biocon Q1 net profit slumps 51 percent to Rs 81 crore

    Biocon Q1 net profit slumps 51 percent to Rs 81 crore

    Ruby Khatun Khatun5 Aug 2017 9:16 AM IST
    New Delhi: Bio-pharmaceutical firm Biocon reported a 51.20 per cent decline in its consolidated net profit to Rs 81.3 crore for the quarter ended...
    Lupin first-quarter profit slumps, misses estimates

    Lupin first-quarter profit slumps, misses estimates

    Ruby Khatun Khatun4 Aug 2017 9:15 AM IST
    Drugmaker Lupin Ltd said on Wednesday first quarter profit fell 59 percent, well below analysts' estimates, as regulatory hurdles and pricing pressure...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok